title: Therapeutic HIV vaccine trial launched in Canada.
abstract: The first-ever clinical trial of a therapeutic HIV vaccine in Canada is currently underway. The trial is being run by the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) in cooperation with Aventis Pasteur, of France, and the Immune Response Corporation (IRC), of the United States.
authors.forename: David
authors.initials: D
authors.lastname: Garmaise
mesh_terms: D016915:AIDS Vaccines / Q000627:therapeutic use*; D002170:Canada; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000628:therapy*; D006801:Humans
chemical_list: D016915:AIDS Vaccines